Pedro Abizanda

Pedro Abizanda

Auto-generated profile, based on publicly available information

Pedro Abizanda

CIBER de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, España; Complejo Hospitalario Universitario de Albacete, Albacete, España; Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, España; Instituto de Investigación de Castilla-La Mancha (IDISCAM), Toledo, España

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
JSJustin Stebbing
Justin Stebbing
GNGinés Sánchez Nievas
Ginés Sánchez Nievas
MFMarco Falcone
Marco Falcone
SYSonia Youhanna
Sonia Youhanna
PRPeter Richardson
Peter Richardson
VLVolker Lauschke
Volker Lauschke
The dual anticytokine and antiviral actions of baricitinib reduce SARS-CoV-2 infectivity in organoids and morbidity in people.

1 January 2012 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
PAPedro Abizanda
Pedro Abizanda
JNJosé Luis Navarro
José Luis Navarro
MGMaría Isabel García-Tomás
María Isabel García-Tomás
ELEsther López-Jiménez
Esther López-Jiménez
EMEsther Martínez-Sánchez
Esther Martínez-Sánchez
GPGema Paterna
Gema Paterna

1 February 2017 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
PDF file
IGI. García-Nogueras
I. García-Nogueras
IAIsaac Aranda-Reneo
Isaac Aranda-Reneo
LLLuz María Peña Longobardo
Luz María Peña Longobardo
JOJuan Oliva-Moreno
Juan Oliva-Moreno
PAPedro Abizanda
Pedro Abizanda
Background Frailty is associated with adverse health outcomes, but its association with hospital healthcare costs has not been analyzed. The main objective was to estimate the adjusted annual costs and use of hospital healthcare resources in frail older adults compared to non frail ones. Design FRADEA Study. Mean follow-up 1044 days (SD 314). Setting Albacete city, Spain. Participants 830 adults ≥70 years. Measurements Age, sex, comorbidity measured with the Charlson index and Fried´s Frailty phenotype as independent variables, and use of hospital resources (hospital admissions, emergency visits, and specialist visits), and hospital healthcare costs as outcome variables. Outcome data were collected from Minimum Data Set of the Complejo Hospitalario Universitario Albacete. The cost base year was 2013. Logistic regression and two-part models were used to analyze the association between frailty and the use of healthcare resources. Generalized Linear Models were applied to estimate the impact of frailty and comorbidity on the healthcare costs. Results The average cost associated with the use of health resources was 1,922€/year. Frail participants had an average total cost of health resources of 2,476€/year, pre-frail 2,056€/year, and non-frail 1,217€/year. 67% of the total health cost was associated with hospital admission cost, 29% with specialist visits cost and 4% with emergency visits cost. Frailty and comorbidity were the most important factors associated with the use of hospital healthcare resources. Adjusted healthcare costs were 592€/year and 458€/year greater in frail and pre-frail participants respectively, compared to non-frail ones, and having a Charlson index ≥ 3, was associated with an increased costs of 2,289€/year. Conclusion Frailty and comorbidity are meaningful and complementary associated with increased hospital healthcare resources use, and related costs.

1 May 2015 in Journal of the American Medical Directors Association
Verified
Journal Article
Open access
PAPedro Abizanda
Pedro Abizanda
MLMateo Díez López
Mateo Díez López
VGVictoria Pérez García
Victoria Pérez García
JEJuan de Dios Estrella
Juan de Dios Estrella
ÁGÁlvaro da Silva González
Álvaro da Silva González
KTKrysmarú Araujo Torres
Krysmarú Araujo Torres
The objective of this study was to assess the effects of a hyperproteic, hypercaloric oral nutritional supplement with prebiotic fiber, vitamin D, and calcium, plus a standardized physical intervention, in the functional status, strength, nutritional status, and quality of life of frail institutionalized older adults. Multicentric prospective observational study under usual clinical practice conditions. Four nursing homes from Burgos (2), Albacete, and Madrid, Spain. Participants included 91 institutionalized older adults (age ≥70), able to walk 50 m, and meeting at least 3 of the Fried frailty phenotype criteria. Daily intake of two 200-mL bottles of an oral nutritional supplement, each bottle containing 300 kcal, 20 g protein, 3 g fiber, 500 IU vitamin D, and 480 mg calcium, plus a standardized physical exercise training consisting of flexibility, balance, and strengthening exercises for arms and legs, 5 days per week. Short Physical Performance Battery (SPPB), Short-Form-Late-Life Function and Disability Instrument (SF-LLFDI) function subscale, handgrip strength, EuroQoL-5 Dimensions visual analogic scale (EQ5DVAS), weight, body mass index (BMI), and Short-Form Mini Nutritional Assessment (MNA-SF) at baseline and 6 and 12 weeks. Forty-eight participants (52.7%) improved at least 1 point in the SPPB at week 6, and 44 (48.4%) did so at week 12; 39 participants (42.9%) improved at least 2 points in the SF-LLFDI at week 6, and 46 (50.5%) at week 12. Participants improved their quality of life measured with the EQ5DVAS by 6% (95% confidence interval [CI] 3%-10%) at week 6, and by 5% (95% CI 0%-10%) at week 12. They also improved their nutritional status (weight gain, BMI increase, and higher MNA-SF scores at 6- and 12-week follow-up). This improvement was higher in participants with more frailty criteria, lower functional level, lower vitamin D levels, and poorer nutritional status. A 12-week intervention with oral nutritional supplementation plus physical exercise improves function, nutritional status, and quality of life in frail institutionalized older adults.

1 January 2016 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
PAPedro Abizanda
Pedro Abizanda
ASAlan Sinclair
Alan Sinclair
NBNúria Barcons
Núria Barcons
LLLuis Lizán
Luis Lizán
LMLeocadio Rodríguez Mañas
Leocadio Rodríguez Mañas

1 January 2018 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
BBBeatriz Bonaga
Beatriz Bonaga
PSPedro M. Sánchez-Jurado
Pedro M. Sánchez-Jurado
MMMarta Martínez-Reig
Marta Martínez-Reig
GAGabriel Ariza
Gabriel Ariza
LMLeocadio Rodríguez Mañas
Leocadio Rodríguez Mañas
PAPedro Abizanda
Pedro Abizanda